Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 300 of 3173 entries
View as:

A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World

Phase: N/A Priority: Normal
NCT ID: NCT04337138 Org: User:
Start: 04/07/20 End: 07/31/20 Due: 07/31/21

Prevenar (13v) Infant Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT02119104 Org: User:
Start: 03/31/14 End: 05/31/16 Due: 05/31/17

First In Human, Phase 1 Study of AG013736 In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01469052 Org: User:
Start: 11/30/02 End: 08/31/04 Due: 08/31/05

A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT06532383 Org: User:
Start: 08/14/24 End: 01/09/25 Due: 01/09/26

Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

Phase: N/A Priority: Normal
NCT ID: NCT01819922 Org: User:
Start: 04/30/13 End: 10/31/13 Due: 10/31/14

Good EULAR Response In Patients With Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01558089 Org: User:
Start: 03/31/13 End: 05/31/15 Due: 05/31/16

Assessment Of Safety And Efficacy Of SU11248 In Patients With Metastatic Colorectal Cancer Who Have Failed Selected Previous Treatments.

Phase: N/A Priority: Normal
NCT ID: NCT00077987 Org: User:
Start: 12/31/03 End: 04/30/05 Due: 04/30/06

A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00542685 Org: User:
Start: 10/31/07 End: 12/31/08 Due: 12/31/09

Changes of Depression After First-year of Tofacitinib in RA Patients

Phase: N/A Priority: Normal
NCT ID: NCT03992781 Org: User:
Start: 07/23/20 End: 02/07/24 Due: 02/07/25

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT00246610 Org: User:
Start: 03/31/06 End: 11/30/07 Due: 11/30/08

Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01082965 Org: User:
Start: 07/31/10 End: 07/31/12 Due: 07/31/13

Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04607837 Org: User:
Start: 04/12/21 End: 06/19/24 Due: 06/19/25

A Double-blind, Parallel Group, Placebo-Controlled Outpatient Trial of PD 00200390 in Adults With Nonrestorative Sleep

Phase: N/A Priority: Normal
NCT ID: NCT00655369 Org: User:
Start: 04/30/08 End: 12/31/08 Due: 12/31/09

A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan

Phase: N/A Priority: Normal
NCT ID: NCT00788047 Org: User:
Start: 11/30/08 End: 01/31/09 Due: 01/31/10

Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients

Phase: N/A Priority: Normal
NCT ID: NCT01042236 Org: User:
Start: 01/31/09 End: 07/31/10 Due: 07/31/11

Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis

Phase: N/A Priority: Normal
NCT ID: NCT03970733 Org: User:
Start: 07/01/19 End: 03/28/22 Due: 03/28/23

A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users

Phase: N/A Priority: Normal
NCT ID: NCT00975481 Org: User:
Start: 10/31/09 End: 02/28/10 Due: 02/28/11

A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.

Phase: N/A Priority: Normal
NCT ID: NCT00838058 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid Cardiomyopathy (Attrwt-CM) And Non-Amyloid Heart Failure Among Patients With Heart Failure (HF).

Phase: N/A Priority: Normal
NCT ID: NCT06029452 Org: User:
Start: 09/01/23 End: 11/14/23 Due: 11/14/24

A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT01366014 Org: User:
Start: 06/30/11 End: 06/30/12 Due: 06/30/13

A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01419041 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05261490 Org: User:
Start: 08/01/22 End: 02/15/24 Due: 02/15/25

A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects.

Phase: N/A Priority: Normal
NCT ID: NCT01091532 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT02850406 Org: User:
Start: 07/05/16 End: 10/02/23 Due: 10/02/24

A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06670170 Org: User:
Start: 11/05/24 End: 01/17/25 Due: 01/17/26